{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:51:17Z","timestamp":1784206277960,"version":"3.55.0"},"reference-count":84,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T00:00:00Z","timestamp":1644883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-137102"],"award-info":[{"award-number":["MOP-137102"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>BRIL (bone restricted ifitm-like; also known as IFITM5) is a transmembrane protein expressed in osteoblasts. Although its role in skeletal development and homeostasis is unknown, mutations in BRIL result in rare dominant forms of osteogenesis imperfecta. The pathogenic mechanism has been proposed to be a gain-of or neomorphic function. To understand the function of BRIL and its OI type V mutant (MALEP BRIL) and whether they could activate signaling pathways in osteoblasts, we performed a luciferase reporter assay screen based on the activity of 26 transcription factors. When overexpressed in MC3T3-E1 and MLO-A5 cells, the MALEP BRIL activated the reporters dependent on MEF2, NFATc, and NR4A significantly more. Additional co-transfection experiments with MEF2C and NFATc1 and a number of their modulators (HDAC4, calcineurin, RCAN, FK506) confirmed the additive or synergistic activation of the pathways by MALEP, and suggested a coordinated regulation involving calcineurin. Endogenous levels of Nr4a members, as well as Ptgs2, were upregulated by MALEP BRIL. Y2H and co-immunoprecipitation indicated that BRIL interacted with CAML, but its contribution as the most upstream stimulator of the Ca2+-calcineurin-MEF2\/NFATc cascade was not confirmed convincingly. Altogether the data presented provide the first ever readout to monitor for BRIL activity and suggest a potential gain-of-function causative effect for MALEP BRIL in OI type V, leading to perturbed signaling events and gene expression.<\/jats:p>","DOI":"10.3390\/ijms23042148","type":"journal-article","created":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T22:44:47Z","timestamp":1644965087000},"page":"2148","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The Osteogenesis Imperfecta Type V Mutant BRIL\/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts"],"prefix":"10.3390","volume":"23","author":[{"given":"Vincent","family":"Maranda","sequence":"first","affiliation":[{"name":"Shriners Hospitals for Children\u2014Canada, Montreal, QC H4A 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-H\u00e9l\u00e8ne","family":"Gaumond","sequence":"additional","affiliation":[{"name":"Shriners Hospitals for Children\u2014Canada, Montreal, QC H4A 0A9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5793-1944","authenticated-orcid":false,"given":"Pierre","family":"Moffatt","sequence":"additional","affiliation":[{"name":"Shriners Hospitals for Children\u2014Canada, Montreal, QC H4A 0A9, Canada"},{"name":"Department of Human Genetics, McGill University, Montreal, QC H3A 0C7, Canada"},{"name":"The Research Institute of the McGill University Health Centre, Montreal, QC H3H 2R9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17052","DOI":"10.1038\/nrdp.2017.52","article-title":"Osteogenesis imperfecta","volume":"3","author":"Marini","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1210\/jc.2013-1505","article-title":"New Genes in Bone Development: What\u2019s New in Osteogenesis Imperfecta","volume":"98","author":"Marini","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajhg.2012.06.011","article-title":"A mutation in the 5\u2032-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus","volume":"91","author":"Semler","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ajhg.2012.06.005","article-title":"A single recurrent mutation in the 5\u2032-UTR of IFITM5 causes osteogenesis imperfecta type V","volume":"91","author":"Cho","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/jbmr.2173","article-title":"A novel IFITM5 mutation in severe atypical osteogenesis imperfecta type VI impairs osteoblast production of pigment epithelium-derived factor","volume":"29","author":"Farber","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/jbmr.2156","article-title":"A nonclassical IFITM5 mutation located in the coding region causes severe osteogenesis imperfecta with prenatal onset","volume":"29","author":"Semler","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/MCD.0000000000000279","article-title":"A novel Ser40Trp variant in IFITM5 in a family with osteogenesis imperfecta and review of the literature","volume":"28","author":"Lim","year":"2019","journal-title":"Clin. Dysmorphol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"728544","DOI":"10.3389\/fgene.2021.728544","article-title":"Whole Exome Sequencing Analysis in Fetal Skeletal Dysplasia Detected by Ultrasonography: An Analysis of 38 Cases","volume":"12","author":"Peng","year":"2021","journal-title":"Front. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s00223-021-00878-5","article-title":"A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report","volume":"109","author":"Makitie","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1287","DOI":"10.1002\/mgg3.1287","article-title":"A novel variant of the IFITM5 gene within the 5\u2032-UTR causes neonatal transverse clavicular fracture: Expanding the genetic spectrum","volume":"8","author":"Wu","year":"2020","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1007\/s00198-016-3709-1","article-title":"DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: Diagnostic yield and mutation spectrum","volume":"27","author":"Bardai","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1210\/jc.2014-3082","article-title":"Type V OI primary osteoblasts display increased mineralization despite decreased COL1A1 expression","volume":"100","author":"Reich","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/jbmr.1891","article-title":"Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation","volume":"28","author":"Shapiro","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/jmedgenet-2012-101307","article-title":"Osteogenesis imperfecta type V: Marked phenotypic variability despite the presence of the IFITM5 c.-14C>T mutation in all patients","volume":"50","author":"Rauch","year":"2013","journal-title":"J. Med. Genet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1359\/jbmr.080412","article-title":"Bril: A novel bone-specific modulator of mineralization","volume":"23","author":"Moffatt","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1359\/jbmr.2000.15.9.1650","article-title":"Type V osteogenesis imperfecta: A new form of brittle bone disease","volume":"15","author":"Glorieux","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1359\/jbmr.070418","article-title":"Natural history of hyperplastic callus formation in osteogenesis imperfecta type V","volume":"22","author":"Cheung","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00256-007-0441-0","article-title":"Hyperplastic callus formation in osteogenesis imperfecta type V: Follow-up of three generations over ten years","volume":"37","author":"Cheung","year":"2008","journal-title":"Skelet. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/jbmr.3180","article-title":"Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation","volume":"32","author":"Blouin","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hickford, D., Frankenberg, S., Shaw, G., and Renfree, M.B. (2012). Evolution of vertebrate interferon inducible transmembrane proteins. BMC Genom., 13.","DOI":"10.1186\/1471-2164-13-155"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sallman, A.M., Bringeland, N., Fredriksson, R., and Schioth, H.B. (2012). The dispanins: A novel gene family of ancient origin that contains 14 human members. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031961"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Liu, J., Li, M., Yang, H., and Zhang, C. (2012). Evolutionary dynamics of the interferon-induced transmembrane gene family in vertebrates. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049265"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1002\/jbmr.2243","article-title":"Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination","volume":"29","author":"Patoine","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Tsukamoto, T., Li, X., Morita, H., Minowa, T., Aizawa, T., Hanagata, N., and Demura, M. (2013). Role of S-palmitoylation on IFITM5 for the interaction with FKBP11 in osteoblast cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0075831"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/jbmr.3802","article-title":"The Unmixing Problem: A Guide to Applying Single-Cell RNA Sequencing to Bone","volume":"34","author":"Greenblatt","year":"2019","journal-title":"J. Bone Miner. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41467-019-14029-w","article-title":"A Wnt-mediated transformation of the bone marrow stromal cell identity orchestrates skeletal regeneration","volume":"11","author":"Matsushita","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41586-019-1104-8","article-title":"The bone marrow microenvironment at single-cell resolution","volume":"569","author":"Tikhonova","year":"2019","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1038\/s41467-021-22517-1","article-title":"Osteocyte transcriptome mapping identifies a molecular landscape controlling skeletal homeostasis and susceptibility to skeletal disease","volume":"12","author":"Youlten","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1128\/MCB.00272-08","article-title":"Normal germ line establishment in mice carrying a deletion of the Ifitm\/Fragilis gene family cluster","volume":"28","author":"Lange","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00774-010-0221-0","article-title":"Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice","volume":"29","author":"Hanagata","year":"2011","journal-title":"J. Bone Miner. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Patoine, A., Husseini, A., Kasaai, B., Gaumond, M.H., and Moffatt, P. (2017). The osteogenic cell surface marker BRIL\/IFITM5 is dispensable for bone development and homeostasis in mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0184568"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jbmr.2363","article-title":"A transgenic mouse model of OI type V supports a neomorphic mechanism of the IFITM5 mutation","volume":"30","author":"Lietman","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bone.2017.11.013","article-title":"Crispr-Cas9 engineered osteogenesis imperfecta type V leads to severe skeletal deformities and perinatal lethality in mice","volume":"107","author":"Rauch","year":"2018","journal-title":"Bone"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21197","DOI":"10.1038\/s41598-020-78403-1","article-title":"Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation","volume":"10","author":"Hanagata","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_37","first-page":"780959","article-title":"Swellings over the Limbs as the Earliest Feature in a Patient with Osteogenesis Imperfecta Type V","volume":"2014","author":"Al","year":"2014","journal-title":"Case Rep. Orthop."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/archdischild-2017-313859","article-title":"Elevated platelet counts in a cohort of children with moderate-severe osteogenesis imperfecta suggest that inflammation is present","volume":"103","author":"Salter","year":"2018","journal-title":"Arch. Dis. Child."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Lazarus, S., McInerney-Leo, A.M., McKenzie, F.A., Baynam, G., Broley, S., Cavan, B.V., Munns, C.F., Pruijs, J.E., Sillence, D., and Terhal, P.A. (2014). The IFITM5 mutation c.-14C > T results in an elongated transcript expressed in human bone; and causes varying phenotypic severity of osteogenesis imperfecta type V. BMC Musculoskelet. Disord., 15.","DOI":"10.1186\/1471-2474-15-107"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1083\/jcb.96.1.191","article-title":"In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria","volume":"96","author":"Sudo","year":"1983","journal-title":"J. Cell Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1359\/jbmr.2001.16.9.1622","article-title":"Establishment of an osteoid preosteocyte-like cell MLO-A5 that spontaneously mineralizes in culture","volume":"16","author":"Kato","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI114253","article-title":"Biochemical analysis of callus tissue in osteogenesis imperfecta type IV. Evidence for transient overmodification in collagen types I and III","volume":"84","author":"Brenner","year":"1989","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"115835","DOI":"10.1016\/j.bone.2020.115835","article-title":"Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V","volume":"145","author":"Whyte","year":"2021","journal-title":"Bone"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Zheng, W.B., Hu, J., Zhang, J., Yang, Z., Wang, O., Jiang, Y., Xia, W.B., Xing, X.P., Yu, W., and Li, M. (2022). Specific Characteristic of Hyperplastic Callus in a Larger Cohort of Osteogenesis Imperfecta Type V. Calcif. Tissue Int., 1\u201313.","DOI":"10.1007\/s00223-021-00932-2"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2106\/JBJS.CC.21.00480","article-title":"An Unusual Presentation of Osteogenesis Imperfecta: A Case Report","volume":"11","author":"Lindsay","year":"2021","journal-title":"JBJS Case Connect."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"622674","DOI":"10.3389\/fendo.2021.622674","article-title":"Case Report: Hyperplastic Callus of the Femur Mimicking Osteosarcoma in Osteogenesis Imperfecta Type V","volume":"12","author":"Deng","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00256-014-1884-8","article-title":"Non-traumatic hypertrophic callus of the fibula mimicking osteosarcoma in osteogenesis imperfecta type V: A case report","volume":"43","author":"Radu","year":"2014","journal-title":"Skelet. Radiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1074\/jbc.M509471200","article-title":"Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation","volume":"281","author":"Gregoire","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3389\/fphar.2017.00604","article-title":"Ca2+\/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy","volume":"8","author":"Duran","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/HYPERTENSIONAHA.114.04467","article-title":"Calcium\/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy","volume":"65","author":"Zhang","year":"2015","journal-title":"Hypertension"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"8765752","DOI":"10.1155\/2019\/8765752","article-title":"Structural and Mechanistic Bases of Nuclear Calcium Signaling in Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes","volume":"2019","author":"Li","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.RA118.005465","article-title":"Muscle A-kinase-anchoring protein-beta-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D","volume":"294","author":"Li","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"30071","DOI":"10.1074\/jbc.M111.253518","article-title":"Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization","volume":"286","author":"Stephens","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chan, W.C.W., Tan, Z., To, M.K.T., and Chan, D. (2021). Regulation and Role of Transcription Factors in Osteogenesis. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22115445"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/jbmr.2240","article-title":"Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression","volume":"29","author":"Kawane","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/jbmr.1492","article-title":"Mef2c deletion in osteocytes results in increased bone mass","volume":"27","author":"Kramer","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.devcel.2007.02.004","article-title":"MEF2C transcription factor controls chondrocyte hypertrophy and bone development","volume":"12","author":"Arnold","year":"2007","journal-title":"Dev. Cell"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Kang, J.Y., Kang, N., Yang, Y.M., Hong, J.H., and Shin, D.M. (2020). The Role of Ca2+-NFATc1 Signaling and Its Modulation on Osteoclastogenesis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103646"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.devcel.2006.04.006","article-title":"Calcineurin\/NFAT signaling in osteoblasts regulates bone mass","volume":"10","author":"Winslow","year":"2006","journal-title":"Dev. Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107321","DOI":"10.1155\/2013\/107321","article-title":"NFAT signaling in osteoblasts regulates the hematopoietic niche in the bone microenvironment","volume":"2013","author":"Sesler","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bone.2011.04.006","article-title":"High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-kappaB ligand in osteoblasts","volume":"49","author":"Lee","year":"2011","journal-title":"Bone"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"35318","DOI":"10.1074\/jbc.M702435200","article-title":"Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption","volume":"282","author":"Yeo","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nm1270","article-title":"NFAT and Osterix cooperatively regulate bone formation","volume":"11","author":"Koga","year":"2005","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bone.2009.05.009","article-title":"NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation","volume":"45","author":"Choo","year":"2009","journal-title":"Bone"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e2960","DOI":"10.1038\/cddis.2017.334","article-title":"Yet another hump for CAML: Support of cell survival independent of tail-anchored protein insertion","volume":"8","author":"Shing","year":"2017","journal-title":"Cell Death Dis."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10930-019-09845-4","article-title":"The Ways of Tails: The GET Pathway and more","volume":"38","author":"Borgese","year":"2019","journal-title":"Protein J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/371355a0","article-title":"Calcium signalling in T cells stimulated by a cyclophilin B-binding protein","volume":"371","author":"Bram","year":"1994","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/bbrc.2000.3442","article-title":"Calcium-modulating cyclophilin ligand desensitizes hormone-evoked calcium release","volume":"276","author":"Tovey","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"16346","DOI":"10.1074\/jbc.273.26.16346","article-title":"Co-localization of calcium-modulating cyclophilin ligand with intracellular calcium pools","volume":"273","author":"Holloway","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/14728222.2017.1279146","article-title":"The NR4A subfamily of nuclear receptors: Potential new therapeutic targets for the treatment of inflammatory diseases","volume":"21","author":"Tajes","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.tem.2009.12.004","article-title":"Prostaglandins in bone: Bad cop, good cop?","volume":"21","author":"Blackwell","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1203\/PDR.0b013e31815efd63","article-title":"High levels of serum prostaglandin E2 in children with osteogenesis imperfecta are reduced by neridronate treatment","volume":"63","author":"Finocchiaro","year":"2008","journal-title":"Pediatr. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/sj.jp.7211050","article-title":"Cortical hyperostosis in an infant on prolonged prostaglandin infusion: Case report and literature review","volume":"24","author":"Velaphi","year":"2004","journal-title":"J. Perinatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jpeds.2007.02.066","article-title":"Cortical hyperostosis secondary to prostaglandin E1 therapy","volume":"151","author":"Estes","year":"2007","journal-title":"J. Pediatr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3389\/fendo.2019.00375","article-title":"Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1359\/jbmr.2002.17.6.963","article-title":"Cyclo-oxygenase 2 function is essential for bone fracture healing","volume":"17","author":"Simon","year":"2002","journal-title":"J. Bone Miner. Res"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41467-018-08097-7","article-title":"Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1172\/JCI131554","article-title":"Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones","volume":"130","author":"Hu","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bone.2009.08.061","article-title":"Nuclear factor of activated T cells mediates fluid shear stress- and tensile strain-induced Cox2 in human and murine bone cells","volume":"46","author":"Minematsu","year":"2010","journal-title":"Bone"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bone.2010.05.006","article-title":"Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice","volume":"47","author":"Xu","year":"2010","journal-title":"Bone"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1074\/jbc.275.1.197","article-title":"Ca2+-dependent gene expression mediated by MEF2 transcription factors","volume":"275","author":"Blaeser","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"e07217","DOI":"10.7554\/eLife.07217","article-title":"Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation","volume":"4","author":"Li","year":"2015","journal-title":"eLife"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41589-020-0553-6","article-title":"PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function","volume":"16","author":"Rajan","year":"2020","journal-title":"Nat. Chem. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2148\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:20:12Z","timestamp":1760134812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/4\/2148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":84,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23042148"],"URL":"https:\/\/doi.org\/10.3390\/ijms23042148","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}